(1)
Tacke, MD, PhD, U.; Uosukainen, MSci (Pharm), H.; Kananen, BSci (Pharm), M.; Kontra, Pharm Lic, K.; Pentikäinen, MD, H. A Pilot Study about the Feasibility and Cost-Effectiveness of Electronic Compliance Monitoring in Substitution Treatment With buprenorphine—naloxone Combination. J of Opioid Management 2018, 5, 321-329.